Spelling suggestions: "subject:"synthetase"" "subject:"synthases""
11 |
Transfer RNA and early life evolution /Tong, Ka Lok. January 2005 (has links)
Thesis (Ph.D.)--Hong Kong University of Science and Technology, 2005. / Includes bibliographical references (leaves 107-118). Also available in electronic version.
|
12 |
Characterizing the Function of Alanyl-tRNA Synthetase Activity in Microbial TranslationKelly, Paul Michael January 2020 (has links)
No description available.
|
13 |
Biochemical Characterization of <i>Trypanosoma cruzi </i> Prolyl-tRNA SynthetaseOshule, Paul Sifuna 01 August 2014 (has links)
No description available.
|
14 |
Characterization of Fidelity Mechanisms in Protein TranslationVargas-Rodriguez, Oscar E. 08 September 2014 (has links)
No description available.
|
15 |
Mécanismes et évolution des complexes ribonucléoprotéiques responsables de la biosynthèse ARNt-dépendante des acides aminés / Mechanisms and evolution of the ribonucleoprotein complexes involved in the tRNA-dependent amino acid biosynthesisFischer, Frédéric 28 September 2012 (has links)
La traduction implique l’utilisation d’aminoacyl-ARNt produits par les aminoacyl-ARNt synthétases (aaRS). Il devrait exister 20 aaRS, une spécifique de chaque acide aminé. Or, les données actuelles montrent qu’une grande majorité des organismes ne possèdent pas l’asparaginyl- (AsnRS) et/ou la glutaminyl-ARNt synthétase (GlnRS). Ils ne peuvent synthétiser l’Asn-ARNtAsn et le Gln-ARNtGln que par l’utilisation de voies impliquant la formation préalable d’aspartyl-ARNtAsn et/ou de glutamyl-ARNtGln. Ces précurseurs « mésacylés » sont synthétisés par une aspartyl-ARNt synthétase et/ou une glutamyl-ARNt synthétase non-discriminantes (AspRS-ND ou GluRS-ND). Ils sont ensuite amidés par une amidotransférase (AdT), pour fournir à la cellule l’Asn-ARNtAsn et/ou le Gln-ARNtGln nécessaires à la traduction des codons Asn et Gln.Ce travail de thèse, effectué dans le contexte biologique de deux organismes différents, Thermus thermophilus et Helicobacter pylori, a permis de montrer que les étapes enzymatiques – formation du précurseur, et amidation par l’AdT – sont réalisées au sein de complexes ribonucléoprotéiques, réunissant l’aaRS-ND, l’ARNtAsn ou l’ARNtGln, et l’AdT : l’Asn-transamidosome ou le Gln-transamidosome. Selon leur origine ou la voie à laquelle ils appartiennent (asparaginylation ou glutaminylation), ces complexes possèdent des particularités mécanistiques et structurales très différentes, mais sont tous adaptés pour éviter la libération des intermédiaires mésacylés toxiques par des stratégies spécifiques. Ce travail permet de mieux comprendre les mécanismes évolutifs qui ont conduit à l’incorporation de l’Asn et de la Gln dans le code génétique. / Protein synthesis requires the biosynthesis of aminoacyl-tRNAs by aminoacyl-tRNA synthétases (aaRS). Since 20 amino acids are présent within the genetic code, 20 aaRS should be used by a single organism. However, the vast majority of organisms found today are deprived of asparaginyl- and/or glutaminyl-tRNA synthetases (Asn- or GlnRS). They can only synthesize Asn-tRNAAsn and/or Gln-tRNAGln through biosynthesis pathways involving the preliminary formation of aspartyl-tRNAAsn and /or glutamyl-tRNAGln. Those « misacylated » precursors are synthesized by so called non-discriminating aspartyl- or glutamyl-tRNA synthetases (ND-AspRS or –GluRS). Then, they are transferred to an amidotransferase (AdT) to provide the Asn-tRNAAsn and/or Gln-tRNAGln species (necessary to fuel protein synthesis) through amidation.This work was performed in the context of two organisms – Thermus thermophilus and Helicobacter pylori. It showed that the two enzymatic steps of asparaginylation and glutaminylation – biosynthesis of the misacylated precursor and amidation by AdT – are carried out within a single ribonucleoprotein complex, namely the (Asn- or Gln-) transamidosome, gathering the ND-aaRS necessary for the misacylation, the tRNA substrate (Asn or Gln) and the AdT. According to their origin or the pathway they originate from (asparaginylation or glutaminylation), those complexes display significant mechanistical and structural peculiarities, but they are all adapted to prevent libération of the toxic misacylated species through specific strategies. This work shed new light on the évolutive mechanisms that led to the incorporation of Asn or Gln into the genetic code.
|
16 |
Adenylate forming enzymes involved in NRPS-independent siderophore biosynthesisSchmelz, Stefan January 2010 (has links)
Activation of otherwise unreactive substrates is a common strategy in chemistry and in nature. Adenylate-forming enzymes use adenosine monophosphate to activate the hydroxyl of their carboxylic substrate, creating a better leaving group. In a second step this reactive group is replaced in a nucleophilic elimination reaction to form esters, amides or thioesters. Recent studies have revealed that NRPS- independent siderophore (NIS) synthetases are also adenylate-forming enzymes, but are not included in the current superfamily description. NIS enzymes are involved in biosynthesis of high-affinity iron chelators which are used for iron acquisition by many pathogenic microorganisms. This is an important area of study, not only for potential therapeutic intervention, but also to illuminate new enzyme chemistries. Here the structural and biochemical studies of AcsD from Pectobacterium chrysanthemi are reported. AcsD is a NIS synthetase involved in achromobactin biosynthesis. The co-complex structures of ATP and citrate provide a mechanism for the stereospecific formation of an enzyme-bound citryl-adenylate. This intermediate reacts with L-serine to form a likely achromobactin precursor. A detailed characterization of AcsD nucleophile profile showed that it can not only catalyze ester formation, but also amide and possibly thioester formation, creating new stereospecific citric acid derivatives. The structure of a N-citryl-ethylenediamine product co-complex identifies the residues that are important for both recognition of L-serine and for catalyzing ester formation. The structural studies on the processive enzyme AlcC, which is involved in the final step of alcaligin biosynthesis of Bordetella pertussis, show that it has a similar topology to AcsD. It also shows that ATP is coordinated in a manner similar to that seen in AcsD. Biochemical studies of a substrate analogue establish that AlcC is not only capable of synthesizing substrate dimers and trimers, but also able to assemble the respective dimer and trimer macrocycles. A series of docked binding models have been developed to illustrate the likely substrate coordination and the steps along dimerization and macrocyclization formation. Structural and mechanistic comparison of NIS enzymes with other adenylate-forming enzymes highlights the diversity of the fold, active site architecture, and metal coordination that has evolved. Hence, a new classification scheme for adenylate forming enzymes is proposed.
|
17 |
Identification and Engineering of Nonribosomal Peptide Biosynthetic SystemsXu, Fuchao 01 December 2018 (has links)
This research focuses on the understanding and engineering of nonribosomal peptide biosynthetic pathways in Streptomyces coelicolor CH999, Escherichia coli BAP1 and Saccharomyces cerevisiae BJ5464-NpgA. The biosynthetic systems of indigoidine from bacteria and beauvericin/bassianolide from fungi were studied in this research. The production of these valuble products was significantly increased by enhancing their synthetic pathway with metabolic engineering approaches.
Indigoidine is a bacterial natural product with antioxidant and antimicrobial activities. Its bright blue color resembles the industrial dye indigo, thus representing a new natural blue dye that may find uses in industry. Indigo is a dark blue crystalline powder and has been known for more than 4,000 years. It is commonly used to dye cotton yarn for the production of denim cloth to make blue jeans but the chemical synthesis of indigo requires harsh conditions and use of a strong base. Indigoidine is a new natural blue dye that is vi assembled from two molecules of L-glutamine under the catalysis of indigoidine synthetase. We identified a novel indigoidine synthetic gene from the genome of Streptomyces chromofuscus ATCC 49982. The successful heterologous expression of Sc-indC in E. coli BAP1 give us a pretty good yield of indigoidine under the optimized conditions. The production of this blue dye was then further improved by introducing two additional genes, sc-indB and glnA, into the biosynthetic pathway.
Beauvericins and bassianolide are anticancer natural products from fungi and are assembled by corresponding iterative nonribosomal peptide synthetases. The beauvericin (BbBEAS) and bassianolide (BbBSLS) synthetases were successfully reconstituted in S. cerevisiae BJ5464-NpgA, leading to the production of beauvericins and bassianolide, respectively. The production of beauvericins was significantly improved by co-expression of BbBEAS and ketoisovalerate reductase (KIVR). To better understand the synthetic strategy of fungal iterative NRPs, the module/domain of BbBSLS and BbBEAS were dissected and reconstituted in S. cerevisiae. The result shows the intermodular linker is essential for the reconstitution of the separate modules and the domain swapping results indicated the fungal iterative NRPSs use a liner biosynthetic route which is different than bacterial iterative NRPs. The in vitro reactions of C2 and C3 with monomer/dimer/trimerN-acetylcysteamines demonstrated that C2 forms the amide bond and C3 catalyses the synthesis of the ester bond. Beauvericin could be reconstituted in vitro through co-reaction of C2(BbBEAS) and C3(BbBEAS) with D-Hiv-SNAC and N-Me-L-Phe- SNAC. This work also provides an unprecedented tool for engineering fungal iterative NRPSs to yield ‘unnatural’ cyclooligomer depsipeptides with varied chain lengths.
|
18 |
The Synthesis and Evaluation of Functionalised Carbohydrates as Probes of Tumour MetastasisAbu-Izneid, Tareq, n/a January 2005 (has links)
Sialyltransferases, CMP-sialic acid synthetases and CMP-sialic acid transport proteins play a crucial role in the construction of cell surface glycoconjugates. These proteins also have a pivotal role to play in a number of diseases, including cancer. The sialyltransferase enzymes are responsible for transfering sialic acids from the donor substrate (CMP-sialic acid) to growing cell surface glycoconjugate chains within the Golgi apparatus. The CMP-sialic acid synthetase enzymes are responsible for the synthesis of the CMP-sialic acid, the donor substrate of the sialyltransferases in the nucleus, while the CMP-sialic acid transport proteins are responsible for transporting CMP-sialic acid from the Cytosol to the Golgi apparatus. When these proteins function in an abnormal way, hypersialylation results, leading to an increased level of sialylation on the cell surface. This increased level of sialylation aids in the detachment of primary tumour cells due to an increase in the level of overall negative charge, causing repulsion between the cancer cells. Therefore, the sialyltransferase enzymes, CMP-sialic acid synthetases and CMP-sialic acid transport proteins are intimately involved in the metastatic cascade associated with cancer. Chapter 1 provides a general introduction of cancer metastasis, discussing the roles of three target proteins (CMP-sialic acid synthetases, CMP-sialic acid transport proteins and sialyltransferases), as well as discussing their substrate specificities, with an emphasis on their involvements in cancer metastasis. The Chapter concludes with an overview of the types of compounds intended to be utilised as probes or inhibitors of these proteins. Chapter 2 describes the general approach towards the synthesis of CMP-Neu5Ac mimetics with a sulfur linkage in the presence of a phosphate group in the general structure 38. The precursor phosphoramidite derivative 45 was prepared and isolated in a good yield using Py.TFA. Unfortunately, the target compound 38 could not be prepared. Chapter 3 describes an alternative strategy wherein S-linked sialylnucleoside mimetics, of the general structure 39, with a sulfur linkage, but no phosphate group, between the sialylmimetic and the ribose moiety in the base is targeted. A series of these S-linked sialylnucleoside mimetics were successfully prepared. Cytidine, uridine, adenosine and 5-fluorouridine nucleosides were used to create a library of different nucleosides and with structural variability also present in the sialylmimetic portion. This small 'library' of 15 compounds was designed to shed light on the interaction of these compounds with the binding sites of the sialyltranferase, CMP-sialic acid synthetase and/or CM-sialic acid transport protein. Approaches towards the synthesis of O-linked sialylnucleoside mimetics of the general structure 40 are described in Chapter 4. Several methodologies are reported, as well as protecting group manipulations, for successful preparation of these sialylnucleoside mimetics. Cytidine and uridine were employed as the nucleosides, thus allowing a direct comparison between the O- and S-linked sialylnucleoside mimetics in biological evaluation. It appears from these synthetic investigations that gaining access into the O-linked series is not as straightforward as for the S-linked series, with alternative protecting group strategies required for the different nucleosides. The biological evaluation of some of the compounds reported in Chapters 3 and 4 is detailed in Chapter 5. The sialylnucleoside mimetics were evaluated, by 1H NMR spectroscopy, for their ability to inhibit CMP-KDN synthetase. In addition, an initial 1H NMR spectroscopic-based assay was investigated for inhibition studies of α(2,6)sialyltranferase in the absence of potential inhibitors. The final chapter (Chapter 6) brings together full experimental details in support of the compounds described in the preceding Chapters.
|
19 |
Role of phenylalanyl-tRNA synthetase in translation quality controlLing, Jiqiang, January 2008 (has links)
Thesis (Ph. D.)--Ohio State University, 2008. / Title from first page of PDF file. Includes vita. Includes bibliographical references (p. 119-137).
|
20 |
Mechanisms of type VI secretion system effector transport and toxicityAhmad, Shehryar January 2021 (has links)
The type VI secretion system (T6SS) is a protein export pathway that mediates competition between Gram-negative bacteria by facilitating the injection of toxic effector proteins from attacking cells into target cells. To function properly, many T6SSs require at least one protein that possesses a proline-alanine-alanine-arginine (PAAR) domain. These PAAR domains are often found within large, multi-domain effectors that possess additional N- and C-terminal extension domains whose function in type VI secretion is not well understood. The work described herein uncovers the function of these accessory domains across multiple PAAR-containing effectors. First, I demonstrated that thousands of PAAR effectors possess N-terminal transmembrane domains (TMDs) and that these effectors require a family of molecular chaperones for stability in the cell prior to their export by the T6SS. Our findings are corroborated by co-crystal structures of chaperones in complex with the TMDs of their cognate effectors, capturing the first high-resolution structural snapshots of T6SS chaperone-effector interactions. Second, I characterize a previously undescribed prePAAR effector named Tas1. My work shows that the C-terminus of Tas1 possesses a toxin domain that pyrophosphorylates ADP and ATP to synthesize the nucleotides adenosine penta- and tetraphosphate (hereafter referred to as (p)ppApp). Delivery of Tas1 into competitor cells drives the rapid accumulation of (p)ppApp, depletion of ADP and ATP, and widespread dysregulation of essential metabolic pathways, resulting in target cell death. These findings reveal a new mechanism of interbacterial antagonism, the first characterization of a (p)ppApp synthetase and the first demonstration of a role for (p)ppApp in bacterial physiology. TMD- and toxin-containing PAAR proteins constitute a large family of over 6,000 T6SS effectors found in Gram-negative bacteria. My work on these proteins has uncovered that different regions found within effectors have distinct roles in trafficking between bacterial cells and in the growth inhibition of the target cell. / Dissertation / Doctor of Philosophy (PhD) / Bacteria constantly compete with their neighbours for resources and space. The type VI secretion system is a protein complex that facilitates competition between Gram-negative bacteria by facilitating the injection of protein toxins, also known as effectors, from attacking cells into target cells. In this work, I characterize several members of a large family of membrane protein effectors. First, I showed that these effectors require a novel family of chaperone proteins for stability and recruitment to the type VI secretion system apparatus. Second, I characterized the growth-inhibitory properties of one of these effectors in-depth and showed that it possesses a toxin domain that depletes the essential nucleotides ATP and ADP in target cells by synthesizing the nucleotides adenosine penta- and tetraphosphate, (p)ppApp. Together, these studies revealed a new mechanism for the intercellular delivery of membrane protein toxins and uncovered the first known physiological role of a (p)ppApp-synthesizing enzyme in bacteria.
|
Page generated in 0.0331 seconds